Amarin Corp Plcuk (AMRN) Tax Provisions (2010 - 2026)
Amarin Corp Plcuk (AMRN) posted quarterly Tax Provisions of $1.8 million for Q1 2026, down 13.45% YoY from $2.1 million in Q1 2025, and up 380.91% sequentially from $372000.0 in Q4 2025.
Amarin Corp Plcuk (AMRN) Tax Provisions (2010 - 2026) Analysis & Trends
Amarin Corp Plcuk has disclosed Tax Provisions across 14 years of filings, most recently posting $1.8 million for Q1 2026.
- In Q1 2026, Tax Provisions fell 13.45% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $2.5 million (down 57.01% YoY), while the FY2025 annual figure was $2.8 million, down 44.81% from the prior year.
- Tax Provisions rose to $1.8 million in Q1 2026, from $372000.0 in the prior quarter.
- Over the last five years, Tax Provisions for AMRN reached as high as $5.2 million in Q2 2022 and fell as low as -$7.6 million in Q4 2022.
- The 5-year median for Tax Provisions is $1.3 million (2024), against an average of $997882.4.
- Annual changes were most pronounced in 2022 — Tax Provisions tumbled 550.09% — and 2024, when it surged 619.56%.
- A 5-year view of Tax Provisions shows it stood at -$7.6 million in 2022, then jumped by 143.68% to $3.3 million in 2023, then slumped by 138.69% to -$1.3 million in 2024, then surged by 128.86% to $372000.0 in 2025, then jumped by 380.91% to $1.8 million in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $1.8 million, $372000.0, and -$377000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.45 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 755.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 342.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 3.08 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 709.00 Mn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 265.00 Mn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 559.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 461.00 Mn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -683.00 Mn |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn | 1.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.79 Mn |
| Dec 31, 2025 | 372,000.00 |
| Sep 30, 2025 | -377,000.00 |
| Jun 30, 2025 | 689,000.00 |
| Mar 31, 2025 | 2.07 Mn |
| Dec 31, 2024 | -1.29 Mn |
| Sep 30, 2024 | 3.61 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Mar 31, 2024 | 1.30 Mn |
| Dec 31, 2023 | 3.33 Mn |
| Sep 30, 2023 | 501,000.00 |
| Jun 30, 2023 | -355,000.00 |
| Mar 31, 2023 | 1.96 Mn |
| Dec 31, 2022 | -7.63 Mn |
| Sep 30, 2022 | 1.26 Mn |
| Jun 30, 2022 | 5.16 Mn |
| Mar 31, 2022 | 3.21 Mn |
| Dec 31, 2021 | 1.70 Mn |
| Sep 30, 2021 | 184,000.00 |
| Jun 30, 2021 | 1.06 Mn |